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ABSTRACT Glucocorticoid hormones are critical to
respond and adapt to stress. Genetic variations in the
glucocorticoid receptor (GR) gene alter hypothalamic-
pituitary-adrenal (HPA) axis activity and associate with
hypertension and susceptibility tometabolic disease. Here
we test the hypothesis that reduced GR density alters
blood pressure and glucose and lipid homeostasis and
limits adaption to obesogenic diet. HeterozygousGRgeo/
mice were generated from embryonic stem (ES) cells with
a gene trap integration of a -galactosidase-neomycin
phosphotransferase (geo) cassette into the GR gene
creating a transcriptionally inactive GR fusion protein.
Although GRgeo/ mice have 50% less functional GR,
they have normal lipid and glucose homeostasis due to
compensatory HPA axis activation but are hypertensive
due to activation of the renin-angiotensin-aldosterone
system (RAAS). When challenged with a high-fat diet,
weight gain, adiposity, and glucose intolerance were sim-
ilarly increased in control and GRgeo/ mice, suggesting
preserved control of intermediary metabolism and energy
balance. However, whereas a high-fat diet caused HPA
activation and increased blood pressure in control mice,
these adaptions were attenuated or abolished in GRgeo/
mice. Thus, reduced GR density balanced by HPA activa-
tion leaves glucocorticoid functions unaffected but min-
eralocorticoid functions increased, causing hypertension.
Importantly, reduced GR limits HPA and blood pressure
adaptions to obesogenic diet.—Michailidou, Z., Carter,
R. N., Marshall, E., Sutherland, H. G., Brownstein, D. G.,
Owen, E., Cockett, K., Kelly, V., Ramage, L., Al-Dujaili,
E. A. S., Ross, M., Maraki, I., Newton, K., Holmes, M. C.,
Seckl, J. R., Morton, N. M., Kenyon, C. J., Chapman, K. E.
Glucocorticoid receptor haploinsufficiency causes hyper-
tension and attenuates hypothalamic-pituitary-adrenal axis
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Glucocorticoids coordinately regulate gene
pathways in response to external (stress) and internal
(circadian) cues and form part of important homeo-
static control mechanisms, critical in adaption to envi-
ronmental stressors. They are required for the integrity
of central nervous system function, for the response to
infection and injury, and for cardiovascular and meta-
bolic homeostasis. They regulate blood pressure (1),
energy intake and expenditure, and glucose and lipid
homeostasis (2). In excess, glucocorticoids cause hyper-
tension, visceral obesity, insulin resistance/diabetes,
and disordered mood and cognition (Cushing’s syn-
drome), whereas glucocorticoid deficiency causes hy-
potension, fatigue, weight loss, and anorexia.
Most actions of glucocorticoids are mediated
through the widely distributed glucocorticoid receptor
(GR; refs. 3–5), which belongs to the superfamily of
nuclear receptor transcription factors (6). Studies in
vitro (7, 8) and in vivo (9, 10) have shown the impor-
tance of receptor density in determining cellular glu-
cocorticoid sensitivity. Complete loss of GR is incom-
patible with postnatal survival (11, 12), but partial loss
of GR function in humans causes the rare familial/
sporadic glucocorticoid resistance syndrome (13), char-
acterized by hypercortisolism without other features of
Cushing’s syndrome. Polymorphisms in the human
Nr3c1 gene (encoding GR; here abbreviated to GR) are
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associated with hyper- or hyposensitivity to exogenous
glucocorticoid (dexamethasone) suppression of the
hypothalamic-pituitary-adrenal (HPA) axis and a range
of metabolic and cardiovascular parameters. Thus,
polymorphisms associated with glucocorticoid hyper-
sensitivity (BclI, N363S) are typically (dependent on
age, gender, and ethnic background) associated with
hypertension, obesity, decreased lean mass, insulin
resistance, and increased risk of cardiovascular disease
despite reduced plasma cortisol levels, whereas the
ER22/23EK polymorphism, associated with glucocorti-
coid hyposensitivity, is associated with beneficial meta-
bolic outcomes (reviewed in ref. 14).
Several mouse lines with altered GR expression or
function have been generated to investigate the role of
GR in HPA axis regulation and its role in mood
regulation and in the immune system (reviewed in refs.
15–17). Fewer studies have investigated the effects of
altered GR density on cardiovascular and metabolic
outcomes. Reduced GR density through antisense GR
transgene expression (central nervous system targeted,
although widely expressed) lowered energy intake but
also caused obesity (18, 19). However, neuron-specific
deletion of GR caused a small-lean phenotype post-
weaning and increased energy expenditure, due to the
peripheral effects of high glucocorticoid levels coupled
with normal levels of peripheral GR (20). Liver-specific
GR gene deletion led to hypoglycemia, but only after
prolonged starvation, and ameliorated hyperglycemia
in streptozotocin-induced diabetes (21). Recently, trans-
genic mice have been described with cardiomyocyte-
specific GR overexpression. These mice display conduc-
tion defects, reduced heart rate, atrioventricular block,
altered calcium homeostasis, and ion channel remod-
eling in isolated cardiomyocytes (22). Although these
studies have provided important information on the
tissue-specific functions of GR, the cardiovascular and
metabolic consequences of globally altered GR density,
and hence glucocorticoid sensitivity, have not been de-
scribed, although this is the clinically relevant situation.
Here we have generated a novel line of mice with
reduced GR density, heterozygous for a null mutation
of the GR gene (GRgeo/), to investigate whether global
reduction in GR density alters cardiovascular (blood
pressure), fat distribution, and metabolic (glucose and
lipid homeostasis) parameters. A high-fat (HF) diet was
introduced to determine whether GR haploinsuffi-
ciency altered the adaptive hormonal and metabolic
changes that accompany dietary-induced obesity.
MATERIALS AND METHODS
Generation of GRgeo/ mice
A mouse ES cell line (ESKN92) generated by gene-trap
mutagenesis in which a -galactosidase-neomycin phospho-
transferase (geo) reporter cassette integrated within the GR
gene, generating a translational fusion between GR and geo,
has been described previously (23). 5-Rapid amplification of
cDNA ends (RACE) confirmed integration of the -galacto-
sidase-neomycin phosphotransferase (geo) reporter cassette
between exons 3 and 4 of the GR gene. Fluorescence in situ
hybridization (FISH) confirmed a single integration site on
chromosome 18 at the GR locus. Chimeric mice were gener-
ated by injection of ESKN92 cells into C57BL/6J blastocysts.
Chimeras were mated to C57BL/6J female mice to achieve
germ line transmission and further backcrossed to generate a
congenic line (full name, Nr3c1gtESK92MRCHGU; here abbrevi-
ated to GRgeo). Heterozygotes were identified by polymerase
chain reaction (PCR) for the presence of lacZ (in the geo
cassette) using the following primers: forward, 5-GTTGC-
GCAGCCTGAATGGCG-3; and reverse, 5-GCCGTCACTC-
CAACGCAGCA-3. All the experiments described were per-
formed on adult male (5–6 months) GRgeo/ and GR/
littermates, backcrossed for five generations (F5) to C57BL/
6J. Experimental groups were 8 to 9 per group, unless
otherwise stated. To generate homozygous GRgeo/geo mice,
F7 GR
geo/ mice were intercrossed.
Animal maintenance and diets
All animal experimentation was conducted in strict accord
with the accepted standards of humane animal care under
the auspices of the Animal (Scientific Procedures) Act UK
1986 after prior approval by the local ethical committee. Mice
were housed in standard cages under controlled lighting
(12:12-h light-dark cycle, lights on at 7 AM) and were fed
standard chow from weaning unless specified otherwise. For
measurement of unstressed plasma corticosterone ACTH and
glucose in tail nick blood samples, animals were acclimatized
to single housing and tail nicks were performed within 1 min
of disturbing the cage. For diet-induced obesity experiments,
mice were weaned onto either HF/low carbohydrate diet
(58% kcal as fat, D12331; Research Diets, New Brunswick, NJ,
USA) or low-fat (LF)/high-carbohydrate diet (11% kcal as fat,
D12328; Research Diets) and remained on the diet for 22 wk
with ad libitum access to water and diet. Body weight and food
intake were monitored weekly and for 3 wk, respectively.
Tissue collection, metabolic parameters, and liver
triglyceride levels
Experimental mice were killed by decapitation between 8 and 10
AM. Trunk blood samples were collected into EDTA-coated
tubes (Sarstedt, Nu¨mbrecht, Germany) and centrifuged (6000 g,
10 min), and plasma was stored at 80°C before assay. Tissues
were rapidly frozen in dry ice for RNA or Western blot analysis
or fixed in formalin (left adrenal, kidney) for histology. Evening
plasma corticosterone levels were determined from blood sam-
pled (by tail nick) at 7 PM. Plasma corticosterone was measured
by an in-house radioimmunoassay as described previously (24).
Plasma ACTH levels were measured by ELISA (Biomerica,
Newport Beach, CA, USA). For the glucose tolerance test
(GTT), animals were deprived of food for 6 h, 2 mg/g body
weight of 25% glucose was injected intraperitoneally, and tail
nick blood sampling was performed at time 0 (before injection)
and 15, 30, 60, and 120 min after injection. Plasma glucose was
measured using a glucose monitoring system (One Touch Ultra,
Lifescan, Johnson & Johnson, Langhorne, PA, USA), insulin by
ELISA (Crystalchem, Downers Grove, IL, USA), nonesterified
fatty acids (NEFAs) with a NEFA C kit (Wako Chemicals GmbH,
Nuess, Germany), and triglycerides with an L-type triglyceride
kit (Wako Chemicals GmbH). Insulin, NEFAs, and triglycerides
were measured after 24 h of food deprivation. Hepatic triglyc-
erides were extracted after homogenization of 100 mg liver in
isopropanol (10 vol) and then incubation at 37°C for 45 min.
After centrifugation (3000 g, 10 min), 10 l supernatant was
incubated at 37°C for 5 min with 1 ml Thermotrace triglyceride
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reagent (Alpha Laboratories, Eastleigh, UK) and absorbance at
500 nm was measured. Plasma renin activity and angiotensino-
gen concentration were measured by radioimmunoassay as
described previously (25). Plasma aldosterone concentration
was measured by in-house ELISA as described previously (26,
27). Formalin-fixed tissues were processed for histopathology,
sectioned (4 m), and stained with hematoxylin and eosin for
histopathological examination.
Blood pressure measurements
Systolic blood pressure was measured on 2 separate days in
conscious mice by tail cuff plethysmography (Harvard Appa-
ratus, Edenbridge, UK) as described previously (28). Before
measurements were recorded, all mice underwent three
periods of training to acclimatize them to the procedure.
Mice were kept at 37°C for 10 min before measurements were
initiated. Mean systolic blood pressure was calculated from
the mean of 12 measurements per mouse.
RNA extraction and real-time PCR
Total RNA was extracted from frozen tissues as described
previously (25). One microgram of RNA was pretreated
with DNaseI (Invitrogen, Paisley, UK) and then reverse
transcribed into cDNA using oligo(dT) primer and Super-
script III first strand cDNA synthesis kit (Invitrogen).
Real-time PCR was carried out on cDNA using a Light-
Cycler 480 (Roche Diagnostics, Burgess Hill, UK) with a
commercial master mix (FAM-hydrolysis probe, Roche
Diagnostics) and the following primer/probe sets (Applied
Biosystems, Foster City, CA, USA): -actin, Mm00607939_s1;
GR, Mm01260497_m1 (amplicon spanning exons 5–6) and
Mm00433832_m1 (amplicon spanning exons 2–3); 11-
HSD1, Mm00476182_m1; angiotensinogen, Mm00599662;
11-HSD2, Mm00492541_g1; and mineralocorticoid receptor
(MR), Mm01241597_m1. Renin primers were in-house prim-
ers as follows: forward, 5-GGTGCCCTCCACCAAGTG-3; re-
verse 5-TCAGAGGACTCATAGAGGCTGTGA-3; and probe,
5-AGCCGCCTCTACCTTGCTTGTGGG-3. Negative con-
trols omitting Superscript III or RNA were included. Anneal-
ing temperature was 60°C. Data were analyzed using the
second derivative maximum method. The ratio of levels of the
transcript of interest to levels of -actin mRNA was deter-
mined for each sample.
In situ mRNA hybridization
Brain and pituitary GR mRNA levels were determined by in
situ mRNA hybridization histochemistry, as described previ-
ously (29). Briefly, coronal brain sections (10 m) were
hybridized overnight at 55°C to 35S-labeled GR cRNA probe
complementary to exons 5–9 of GR (29; absent from ESKN92-
encoded GR-geo mRNA). Sections were then treated with
RNase at 37°C for 1 h and washed at 60–70°C. Hybridized
sections were exposed to autoradiographic film for 7 days. For
densitometry, autoradiographs were imaged on a lightbox
fitted with a coolsnap photometrics camera and analyzed
using MCID software (InterFocus Imaging, Cambridge, UK).
Western blotting
Fifty milligrams of epididymal fat tissue was homogenized in
600 l protein extraction buffer (Invitrogen). Proteins (25 g
homogenate) were resolved on 4–12% Bris-Tris Novex pre-
cast Gels (Invitrogen), transferred to a nitrocellulose mem-
brane, and then incubated with a GR-specific antibody (M-20,
Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immuno-
reactive bands were visualized by chemiluminesense (ECL kit;
Amersham Biosciences, Little Chalfont, UK). An anti--tubu-
lin monoclonal antibody (Sigma Aldrich, St. Louis, MO,
USA) or membrane staining with Ponceau red were used to
verify equal protein loading between samples.
X-gal staining
X-gal (5-bromo-4-chloro-3-indolyl--d-galactopyranoside) staining
to detect -galactosidase activity was carried out on frozen
coronal brain sections (10 m). Sections were transferred
directly from80°C into fixative (4% paraformaldehyde, 0.02%
Nonidet P-40, 0.01% sodium deoxycholate, 5 mM EGTA, and 2
mM MgCl2) for 15 min at 4°C; washed twice in PBS containing
2 mM MgCl2, 0.02% Nonidet P-40, and 0.01% sodium deoxy-
cholate; and stained for 6 h in PBS containing 2 mM MgCl2, 0.02%
Nonidet P-40, 0.01% sodium deoxycholate, 5 mM potassium ferri-
cyanide, 5 mM potassium ferrocyanide, and 1 mg/ml X-gal.
Transfection assays
Human embryonic kidney (HEK293) cells were maintained
in Dulbecco modified Eagle medium (DMEM) supple-
mented with 10% fetal calf serum, 100 U/ml penicillin,
and 100 g/ml streptomycin, at 37°C, 5% CO2. For trans-
fection, 2.5  105 cells were seeded per well in 6-well plates
coated with poly-d-lysine in DMEM supplemented with
10% charcoal-stripped fetal calf serum and transfected the
following day using Lipofectamine 2000 (Invitrogen) with
500 ng reporter plasmid, 200 ng expression plasmid
and/or empty vector, pcDNA3.1() (Invitrogen), and 50
ng pRL-CMV (Promega, Southampton, UK) encoding re-
nilla luciferase, used as internal control. Dexamethasone
(1 M) was added 1 h after transfection, and the cells were
harvested 48 h later for luciferase assays. Reporter plasmids
were MMTV-LTR-luciferase (30) or rPNMT-998/-466 Luc
(31). Expression plasmids encoded wild-type (WT) mouse
GR or GR-geo. WT GR was subcloned from pSV2wrec
(32). A polymorphism within the DNA binding domain of
the pSV2wrec-encoded GR (encoding Val437) (33) was
changed to Gly437, to be identical to the C57BL/6J and
129 mouse strain-encoded GR, by site-directed mutagene-
sis. The GR-geo cDNA was assembled from the WT GR
cDNA, the 5-RACE product, and the pGT3 vector in the
gene trap (23) by subcloning of appropriate DNA frag-
ments. All constructs were verified by DNA sequencing.
Statistical analysis
The effects of genotype and diet were assessed by two-way
ANOVA followed by post hoc Tukey’s tests for group differ-
ences. Significance was set at P 0.05. To evaluate significant
differences in GR mRNA levels between GR/ and GRgeo/
mice, a Student’s t test was used. For GTT comparisons, the
area under the curve was calculated for each animal and then
group means compared with 2-way ANOVA. For transfection
assays, data were analyzed by ANOVA, followed by post hoc
tests. Values are means  se.
RESULTS
GR-geo allele is a null allele that decreases
functional GR levels in heterozygous mice
Generation of GRgeo/ mice
GRgeo/ mutant mice were generated from an ES cell
line (ESKN92) in which a geo reporter cassette had
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integrated into the GR gene, generating a transcrip-
tional and translational fusion (23). 5-RACE carried
out on ESKN92 RNA and PCR analysis of genomic DNA
demonstrated the site of integration between exons 3
and 4 (data not shown). The resulting fusion protein
lacks part of the DNA binding domain and the entire
ligand binding domain (Fig. 1A).
The encoded protein is transcriptionally inactive
The ability of the GR-geo fusion protein to activate
transcription was tested in transfected HEK293 cells,
which lack functional endogenous GR. In contrast to
WT GR, the GR-geo fusion protein had no effect on
promoter activity either in the presence or absence of
dexamethasone (Fig. 1B, C), demonstrating that it is
transcriptionally inactive and that the exon 2–3 en-
coded portion of GR, present in the fusion protein, has
no constitutive activity. Importantly, cotransfection of
GR-geo with WT GR had no effect on dexamethasone-
mediated WT GR transactivation of either MMTV-LTR
(Fig. 1B) or the PNMT promoter (Fig. 1C), demonstrat-
ing that the fusion protein does not exert a dominant-
negative activity. Thus, although the fusion protein is
expressed in GRgeo/ mice (e.g., Fig. 2), these proper-
ties predict that the GR-geo allele is a null allele.
Homozygous GRgeo/geo mice die postnatally
Previous data have shown that homozygosity for a null
allele of GR is lethal (34), whereas 	10–15% of mice
homozygous for a hypomorphic allele survive (11). To
test the lethality of the GR-geo allele, heterozygous
GRgeo/ mice were intercrossed. Of 145 offspring,
none were homozygous for the GR-geo allele, suggest-
ing that homozygous mice die before adulthood, con-
sistent with previous data showing the lethality of a null
allele around birth (11, 34). In contrast, examination of
embryos from heterozygous intercrosses showed the
presence of homozygous GRgeo/geo embryos at the
expected frequency (26.6%).
Functional GR levels are reduced in GRgeo/ mice
X-gal staining of brain sections from GRgeo/ mice
showed expression of GR-geo throughout the brain,
mirroring normal GR mRNA expression (Fig. 2A, B).
Moreover, quantitative PCR (qPCR) measurements of
GR mRNA levels in GR/ and GRgeo/ mice using
primers that span exons 2–3 (present in both normal
GR and GR-geo alleles) did not differ between geno-
types (data not shown). However, in situ mRNA hybrid-
ization histochemistry of GR mRNA, using a probe
complementary to exons 5–9 of GR (absent from
mRNA encoding GR-geo; Fig. 1A) showed a halving in
the full-length GR mRNA levels in the brain (hip-
pocampus and paraventricular nucleus of the hypothal-
amus) and pituitary of GRgeo/ mice compared with
GR/ littermates (Fig. 2B–D; Table 1). Similarly, qPCR
to detect exons 5–6 showed that GRgeo/ mice had
	50% reduced full-length GR mRNA levels in adipose
tissue, muscle, liver, and adrenal gland (Table 1).
Interestingly, the decrease measured in the adrenal
gland was significantly greater than that in adipose
tissue and liver (P0.05; repeated one-way ANOVA),
possibly reflecting developmental effects. Western blot
analysis showed similar reductions in a 95 kDa GR
protein in GRgeo/ mice (Fig. 3). A 191 kDa immuno-
reactive protein, corresponding to the predicted mass
of the GR-geo fusion protein, was detected in GRgeo/
but not in GR/ mouse tissues (Fig. 3).
GRgeo/ mice show altered HPA adaption to HF diet
Differing HPA axis alterations in response to HF diet in
GRgeo/ mice
HF diets stimulate the HPA axis (35) and induce
hypertension (36, 37). It is well known that GR manip-
ulations affect the HPA axis (15). To establish that HPA
axis activity is increased in GRgeo/ mice and to deter-
mine whether reduced GR levels alter the metabolic
adaption to an HF diet, GRgeo/ mice were weaned
onto a defined HF or LF diet and maintained on the
Figure 1. The GR-geo fusion protein is tran-
scriptionally inactive. A) Schematic view of
the functional domains of GR (top), exon
structure of GR cDNA (middle), and predicted
structure of the GR-geo chimeric mRNA (bot-
tom). The N-terminal domain (NTD) of GR is
encoded by exon 2 (exon 1 is noncoding), the
DNA binding domain (DBD) by exons 3–4, and
the ligand binding domain (LBD) by exons
5–9. The geo cassette replaces exons 4–9. B,
C) HEK293 cells were transiently transfected
with WT mouse GR, GR-geo, or “empty” vector
together with MMTV LTR-luciferase (B) or
PMNT-998/-466-luciferase (C) reporters and
then incubated without (white bars) or with
(black bars) 1 M dexamethasone. Data are
means  se of 3 independent experiments, each performed in triplicate. Values are expressed relative to vector, arbitrarily set
to 1. ***P  0.001 vs. untreated mice. Note the log scale for promoter activity. A.U., arbitrary units.
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diets for 22 wk. Although on the LF diet GRgeo/ mice
had elevated plasma corticosterone levels (basal and
peak) compared with GR/ mice (Fig. 4), consistent
with the predicted increase in basal HPA axis activity in
GR deficiency (15), they resisted the HF diet-induced
increase in basal (morning) plasma corticosterone lev-
els (Fig. 4). Thus, while the HF diet increased basal
corticosterone levels in GR/ mice by 	2-fold, it had
no significant effect on basal corticosterone levels in
GRgeo/ mice, resulting in no difference between mice
of the two genotypes fed the HF diet (Fig. 4). Peak
circulating corticosterone levels remained higher in
GRgeo/ mice compared with their GR/ littermates
and were unaffected by diet (Fig. 4B). There was no
significant difference between genotypes in basal
(morning) plasma ACTH levels in either LF-fed (data
not shown) or HF-fed mice (GR/ vs. GRgeo/: 388
and 197 pg/ml, respectively), consistent with the
similar basal plasma corticosterone levels in the latter.
Similarly, there were no significant effects of either
genotype or diet on pituitary POMC mRNA levels,
although there was a trend for the HF diet to increase
Figure 2. GRgeo/ mice have reduced GR mRNA levels in the brain, with normal
distribution of GR-geo expression. A) Representative X-gal stained GRgeo/ brain
section showing strong staining in a pattern identical to GR mRNA distribution in
hippocampal subfields CA1/2, dentate gyrus (DG), and paraventricular nucleus of the
hypothalamus (PVN), with weaker staining in cortex and thalamus. B, C) Representa-
tive autoradiographs showing in situ hybridization of GR mRNA in brain coronal
sections of GR/ mice (B) and GRgeo/ mice (C). D) Quantification of GR mRNA
levels [optical density (OD)] in the PVN of GR/ (white bars) and GRgeo/ mice
(black bars) (n
6/group; *P0.05).
TABLE 1. GRgeo/ mice have half of the normal GR mRNA levels in the brain and peripheral tissues
Tissue
GR mRNA level (AU)
Reduction (%) P valueGR/ GRgeo/
Brain
Hippocampus
CA1 0.4  0.05 0.2  0.03 50 0.002
CA2 0.5  0.06 0.2  0.05 60 0.003
CA3 0.14  0.01 0.06  0.02 57 0.002
DG 0.4  0.03 0.2  0.03 50 0.002
PVN 0.4  0.1 0.2  0.05 50 0.05
Pituitary 0.5  0.07 0.2  0.04 60 0.002
Periphery
Adrenal gland 1.7  0.3 0.6  0.08 65 0.002
Liver 1.0  0.05 0.7  0.06 30 0.002
Epididymal fat 1.3  0.09 0.7  0.05 46 0.0002
Inguinal fat 1.1  0.06 0.6  0.1 45 0.006
Mesenteric fat 0.6  0.07 0.3  0.08 50 0.05
EDL muscle 1.4  0.1 0.6  0.1 57 0.004
Soleus muscle 1.0  0.1 0.5  0.04 50 0.002
Levels of GR mRNA in brain were measured by in situ mRNA hybridization using a cRNA probe complementary to exons 5–9 of GR, absent
from mRNA encoding the GR-geo fusion protein. Levels of full-length GR mRNA in peripheral tissues were measured by qPCR using a
primer-probe set spanning exons 5–6. Student’s t test was performed for comparisons between genotypes (n
6/group). Significance was set at
P  0.05. AU, arbitrary units; CA, cornu ammonis; DG, dentate gyrus; PVN, paraventricular nucleus of the hypothalamus; EDL, extensor longus
digitalis.
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POMC mRNA levels, only in GR/ mice (LF- vs.
HF-fed GR/ mice: 0.70.1 and 1.30.3, n
2 and 5,
respectively, P
0.3; LF- vs. HF-fed GRgeo/ mice:
0.90.2 and 0.90.2, respectively, n
5/group). Strik-
ingly, and similar to basal plasma corticosterone levels,
adrenal weight was significantly higher in LF-fed
GRgeo/ mice compared with their GR/ littermates,
but, in contrast to GR/ mice, in which adrenal weight
was increased by the HF diet, the HF diet had no effect
on adrenal weight in GRgeo/ mice (Fig. 4C). Adrenal
morphology also differed between genotypes, and this
was particularly apparent on the LF diet (Fig. 5). The
morphology suggests stimulation of corticosterone- and
aldosterone-producing cells of GRgeo/ mice in the
zona fasciculata and glomerulosa, respectively. In adre-
nal glands from GRgeo/ mice, the columns of endo-
crine cells in the zona fasciculata are longer than in
GR/ mice, with individual cells having homogeneous
eosinophilic cytoplasm (Fig. 5A–D). The zona glomeru-
losa of GRgeo/ adrenal glands appears thicker than in
GR/ mice, with more glomeruli evident and contain-
ing hypertrophied epithelium (Fig. 5C, D). This adre-
nal phenotype was also apparent in mice fed the HF
diet (Fig. 5E, F), but the morphological differences
between LF and HF groups were more pronounced in
GR/ mice than in GRgeo/ mice (Fig. 5). Measure-
ments of adrenal cell size in the different zones (glo-
merulosa, fascilulata, and reticularis) did not differ
between genotypes (data not shown), indicating that
the larger adrenal glands in GRgeo/ mice reflect
hyperplasia rather than cellular hypertrophy.
Figure 3. GRgeo/ mice have reduced functional GR protein
levels. Representative Western blot analysis showing de-
creased normal GR (95 kDa) in epididymal fat of GRgeo/
(/) mice compared with GR/ (/) mice (top). The
GR-geo fusion protein (191 kDa) was apparent only in
GRgeo/ mice. Tubulin (middle) and ponceau red staining
(bottom) demonstrate equivalent protein loading.
Figure 4. HPA hyperactivity in GRgeo/ mice. A, B) Plasma corticosterone (cort) levels in LF-fed GR/ (white bars), HF-fed
GR/ (hatched bars), LF-fed GRgeo/ (black bars) and HF-fed GRgeo/ mice (gray bars) in the morning (A) and evening (B).
C) Left adrenal weights in LF or HF-fed GR/ and GRgeo/ mice (n
8–9/group). *,†P  0.05; **P  0.01; †††P  0.001. ‡P 
0.01 vs. HF-fed GR/ mice.
Figure 5. GRgeo/ mice have larger adrenal glands. Repre-
sentative images of hematoxylin and eosin stained sections of
adrenal glands from LF-fed GR/ mice (A, C); LF-fed
GRgeo/ mice (B, D); HF-fed GR/ mice (E); and HF-fed
GRgeo/ mice (F). ZF, zona fasciculate; ZG, zona glomeru-
losa; MED, medulla. n 
 8–9/group. Scale bars 
 25 m.
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GRgeo/ mice have normal adipose tissue distribution
and glucose homeostasis but higher liver triglyceride levels
on HF diet
Although GR polymorphisms in humans are associated
with alterations in body weight and/or composition
(reviewed in ref. 14), there were no differences in body
weight (Fig. 6A) or food intake (data not shown)
between GRgeo/ mice and their GR/ littermates, on
either the LF or HF diet. There were also no differences
between genotypes on either diet in weights of adipose
tissue (epididymal, inguinal, and mesenteric) and mus-
cle (extensor digitorum longus) or in plasma levels of
insulin, NEFAs, and triglyceride (Table 2). However,
while the HF diet caused the expected increase in liver
triglyceride levels in both genotypes, levels were higher
in HF-fed GRgeo/ than in GR/ mice (Table 2). Both
genotypes fed the LF diet showed similar responses in
GTTs with an identical impaired response in mice fed
HF diet (Fig. 6B).
GRgeo/ mice are hypertensive and show an
attenuated blood pressure response to HF diet
In LF-fed mice, systolic blood pressure was significantly
elevated (8 mmHg) in GRgeo/ mice compared with
their GR/ littermates (Fig. 7). Furthermore, blood
pressure was increased in both genotypes by the HF
diet, although interestingly the magnitude of the in-
crease was lower in GRgeo/ mice (8 mmHg) than in
GR/ mice (14 mmHg), resulting in no difference in
blood pressure between genotypes in mice fed the HF
diet (Fig. 7).
Figure 6. Unaltered body composition and glucose homeostasis in GRgeo/ mice after HF diet. Body weight (A) and plasma
glucose levels (B) after GTT in LF-fed GR/ mice (open squares, dashed line); HF-fed GR/ mice (open circles, dashed line);
LF-fed GRgeo/ mice (black squares, solid line) and HF-fed GRgeo/ mice (black circles, solid line) (n
6/group). ***P 0.001.
TABLE 2. Similar regional adiposity, lean mass, and plasma insulin and lipid levels in GRgeo/ and GR/ mice
Variable
LF diet HF diet
GR/ GRgeo/ GR/ GRgeo/
Epididymal fat mass
% Body weight 2.08  0.36 1.66  0.38 4.42  0.22*** 4.90  0.38***
Absolute wt (mg) 657  140 489  126 1972  110 2476  285
Inguinal fat mass
% Body weight 1.79  0.31 1.36  0.07 4.22  0.27*** 4.5  0.3.5***
Absolute wt (mg) 559  119 387  23 1914  186 2230  274
Mesenteric fat mass
% Body weight 1.31  0.15 1.07  0.07 2.16  0.13** 2.00  0.17**
Absolute wt (mg) 408  67 301  31 979  92 984  121
Brown adipose mass
% Body weight 0.38  0.03 0.38  0.03 0.62  0.05** 0.79  0.05**
Absolute wt (mg) 118  15 107  8 282  31 381  34
Muscle (EDL) mass
% Body weight 0.24  0.02 0.22  0.02 0.16  0.01** 0.15  0.01**
Absolute wt (mg) 70.3  4 60.8  5 68.6  3 68.8  3
Plasma insulin (ng/ml) 0.2  0.01 0.3  0.1 0.9  0.2* 1.0  0.2*
Plasma NEFA (mEq/l) 0.8  0.1 0.6  0.1 0.65  0.1 0.8  0.1
Plasma TG (mmol/l) 0.44  0.05 0.37  0.06 0.52  0.03 0.47  0.04
Liver TG (mol/g) 5.4  0.7 8.0  1.6 14.8  0.7*** 180.8***
Plasma NEFA, plasma triglyceride (TG), and plasma insulin levels were measured after 24 h fast. *P  0.05; **P  0.01; ***P  0.001 vs.
LF diet. Values in italics indicate a significant difference between genotypes. n 
 8/group.
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GRgeo/ mice have an activated RAAS
Increased systolic blood pressure in GRgeo/ mice was
associated with a 2-fold increase in plasma renin activ-
ity, which was unaffected by diet in either genotype,
remaining higher in GRgeo/ mice (Fig. 8A). Similarly,
plasma aldosterone levels were increased in GRgeo/
mice, irrespective of diet (Fig. 8B). Plasma angio-
tensinogen levels were comparable between LF diet-fed
GRgeo/ and GR/ mice but were markedly increased
(3-fold) by the HF diet only in GRgeo/ mice (Fig. 8C).
Hepatic angiotensinogen mRNA levels mirrored the
pattern of plasma angiotensinogen (Fig. 8E). Increased
adipose tissue expression of angiotensinogen, although
much lower than hepatic expression, has been postu-
lated to contribute to or even underlie hypertension in
diet-induced obesity (38). However, although we ob-
served higher expression of angiotensinogen mRNA in
epididymal adipose tissue of LF-fed GRgeo/ mice com-
pared with GR/ mice, levels were lower in HF-fed
mice and did not differ between genotypes (Fig. 8E).
Neither kidney nor adrenal renin mRNA levels differed
between genotypes on the LF diet nor were they altered
by the HF diet (Table 3). Similarly, renal 11-HSD2
and MR mRNA levels, both critical determinants of
blood pressure (39), were identical between genotypes
and they did not differ with diet (Table 3). Thus,
activation of the RAAS in GRgeo/ mice is likely to
underlie their hypertension but does not account for
changes in blood pressure after the HF diet. The
activation of RAAS in GRgeo/ mice was not accompa-
nied by grossly abnormal kidney function, since kidney
morphology was similar in both genotypes (data not
shown).
DISCUSSION
Although GR polymorphisms are associated with hyper-
tension and differences in body mass index and body
composition in humans, few animal studies have ad-
dressed the effects of altered GR density on body weight
and composition and none have examined the effect
on metabolic adaption to the HF diet. Here we found
that reduced tissue GR density has no effect on body
weight, adipose tissue distribution or glucose homeosta-
sis, basally, on a chow diet (unpublished observations)
or an LF diet or after an HF diet. However, like most
humans heterozygous for mutations in the GR gene,
GRgeo/ mice have an activated HPA axis and, as we
have now shown, elevated blood pressure. Interestingly,
GRgeo/ mice failed to show the full extent of the HPA
and blood pressure adaptions to the HF diet seen in
control mice, suggesting that tissue GR density limits
the adaptive response to chronic dietary stress.
As expected, GRgeo/ mice display a hyperactive HPA
axis, with elevated plasma corticosterone and larger
adrenal glands. The latter results from hyperplasia
rather than cellular hypertrophy, since adrenal cell size
was not different in GRgeo/ mice in any of the zones.
This is consistent with previous data showing increased
plasma corticosterone levels in mice with reduced GR
density (11, 18), although measurements in these pre-
vious studies are likely to have been stress levels. It
differs, however, from a previous study in mice het-
erozygous for a null allele of GR (GRnull/) in which
nonstressed plasma corticosterone levels, both morn-
ing and evening, were the same as in control mice,
although the mice did show an increased plasma corti-
costerone response to stress (40), similar to GRgeo/
mice (our unpublished data). The discrepancy in non-
stressed plasma corticosterone levels between the two
models may be related to environmental or strain
differences: here, backcrossed to C57BL/6J for five
generations, whereas Ridder et al. (40) examined F1
offspring of a C57BL/6J X FVB/N cross. We (41) have
noted higher basal plasma corticosterone levels in
FVB/N mice.
GRgeo/ mice have completely normal body weight,
regional adiposity, and lean mass. Glucose homeostasis
(measured by fasting plasma glucose) and insulin lev-
els, as well as glucose tolerance, were also entirely
normal in GRgeo/ mice. This metabolic phenotype
contrasts with the obesity seen in chow-fed transgenic
mice with globally reduced GR density because of
antisense GR RNA expression (18, 19). These mice,
similar to GRgeo/ mice, also show an activated HPA
axis (18). The reason for the discrepancy between these
two models, each with reduced GR and elevated corti-
costerone, is not clear but may relate to the unknown
effects of the GR transgene in the antisense GR-express-
ing mice in which knockdown of the GR is achieved
through use of a neurofilament gene promoter, which
may be differentially expressed within the central ner-
vous system. Mice with a conditional deletion of the GR
gene in neurons have very high plasma corticosterone
levels due to a lack of negative feedback at the hypo-
thalamus (42). However, these mice have normal pe-
ripheral GR levels, are growth retarded, and have
proportionately more body fat before weaning, but less
Figure 7. GRgeo/ mice have elevated blood pressure. Systolic
blood pressure (SBP) in LF-fed GR/ mice (white bars),
HF-fed GR/ mice (hatched bars), LF-fed GRgeo/ mice
(black bars), and HF-fed GRgeo/ mice (gray bars). *P 0.05;
**,††P  0.01.
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after (20). In GRgeo/ mice, reduced peripheral GR
density may compensate for the increased plasma cor-
ticosterone levels, normalizing body fat distribution.
The lack of effect of genotype on glucose homeostasis
is not surprising, as selective GR gene deletion in
hepatocytes showed that GR is essential for glucose
homeostasis only after prolonged fasting or in a dia-
betic state (21). Moreover, antisense GR mice also show
normal glucose homeostasis (19).
Like most humans heterozygous for inactivating mu-
tations in the GR gene (43), GRgeo/ mice are hyper-
tensive. In GRgeo/ mice, the hypertension results from
elevated activity of the renin-angiotensin-aldosterone
system. Plasma aldosterone levels were increased in
GRgeo/ mice, as was plasma renin activity. The latter,
however, was not associated with increased expression
of renin mRNA in either the kidney or adrenal gland. A
similar discrepancy between plasma renin and mRNA
levels has previously been reported and postulated to
be due to the more rapid secretion and turnover of
newly synthesized renin compared with the long half-
life of renin mRNA (44). Alternatively, renin clearance
may be increased in GRgeo/ mice. Despite reduced GR
density and elevated plasma corticosteroid levels in
GRgeo/ mice, there were no compensatory changes, at
least in the kidney, in the expression of MR or 11-
HSD2, which protects MR from illicit occupation by
glucocorticoids (39). Similarly, MR levels in the brain
are normal in mice with forebrain-specific deletion of
GR (45), suggesting that MR density is not altered to
compensate for reduced GR expression. The increased
plasma aldosterone levels in GRgeo/ mice were consis-
tent with the adrenal histopathology, suggesting high
synthetic activity of aldosterone producing cells. This
was predicted from the phenotype of GRhypo/hypo mice,
which have elevated levels of aldosterone synthase in
Figure 8. Activation of the RAAS in GRgeo/ mice. Plasma renin activity (A), plasma aldosterone concentration (B), plasma
angiotensinogen concentration (C), epididymal fat angiotensinogen (AGT) mRNA levels (D), and hepatic AGT mRNA levels
(E) in LF-fed GR/ mice (white bars), HF-fed GR/ mice (hatched bars), LF-fed GRgeo/ mice (black bars), and HF-fed
GRgeo/ mice (gray bars). For plasma measurements, n
 5/group. For mRNA levels, n
 8–9/group. *,†P 0.05; **,††P 0.01;
***,†††P  0.001.
TABLE 3. Similar expression of mRNAs encoding renin, 11-HSD2, and MR in GRgeo/ and GR/ mice
mRNA Tissue
LF diet HF diet
GR/ GRgeo/ GR/ GRgeo/
Renin Kidney 0.87  0.07 0.95  0.20 0.83  0.09 0.75  0.06
Adrenal 0.98  0.20 1.0  0.10 ND ND
11-HSD2 Kidney 0.85  0.03 0.86  0.09 0.94  0.04 0.77  0.09
MR Kidney 0.80  0.08 0.96  0.20 0.98  0.07 0.99  0.10
Levels of specific mRNAs were measured by qPCR and are expressed in arbitrary units. There were no significant effects of either genotype
or diet upon levels of any of the mRNAs measured (n
6/group).
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the zona glomerulosa (11), and is probably a conse-
quence of elevated plasma ACTH levels in these mice.
Indeed, Pomc/ mice, which lack circulating ACTH,
have small adrenal glands and dramatically reduced
plasma aldosterone levels (46).
HF diets chronically stress the HPA axis in rodents,
increasing basal corticosterone levels and causing adre-
nal enlargement (35, 47), although negative feedback
efficiency is unaffected by HF diet (35). Consistent with
this, in GR/ mice, the HF diet from weaning in-
creased adrenal size and increased morning plasma
corticosterone levels. In contrast, in GRgeo/ mice, the
HF diet had no effect on either of these parameters.
Thus, differences between genotypes in these parame-
ters were eliminated by the diet. Evening (nonstressed)
plasma corticosterone levels were unaffected by the HF
diet and remained higher in GRgeo/ mice. These
results suggest that the HPA axis response to the HF
diet is limited by tissue GR density, this adaptive re-
sponse being abolished by a 50% reduction in GR
levels.
Surprisingly, given the role of glucocorticoids in
energy homeostasis (2), GRgeo/ mice showed an en-
tirely normal body weight gain, altered glucose ho-
meostasis and insulin sensitivity on the HF diet, and did
not differ from GR/ controls. Similarly, mice of both
genotypes fed the HF diet doubled their hepatic accu-
mulation of triglyceride compared with mice on the
control diet, although hepatic triglyceride levels were
significantly higher in HF-fed GRgeo/ mice than in
GR/ mice. Although plasma NEFAs did not differ
between LF- and HF-fed mice, these were measured
after a 24 h fast, when NEFAs release from adipose
tissue constitutes the major energy source and is max-
imal. Glucocorticoids increase hepatic lipogenesis and
secretion (48–50). Furthermore, the consequences of
altered glucocorticoid status on hepatic triglyceride
metabolism are dependent on diet composition (51),
but only when the diet is fed ad libitum (52). Thus, if
lipid flux is low, when animals are maintained on an LF
diet or with the restricted HF diet, then glucocorticoids
minimally affect hepatic triglyceride storage and secre-
tion (52). Whether the increased hepatic triglyceride
levels in GRgeo/ mice are a consequence of the
elevated peak corticosterone levels in these mice
(morning levels did not differ after the HF diet) or a
direct consequence of reduced hepatic GR density
remains to be determined. 11-HSD1 levels are un-
likely to contribute to elevated hepatic triglycerides,
since adipose or liver mRNA levels were unaltered
(unpublished observations).
Blood pressure was increased by the HF diet in both
genotypes, consistent with previous data (36, 37, 53).
However, the magnitude of the HF-induced increase in
blood pressure was smaller in GRgeo/ mice so that
blood pressure in HF-fed GRgeo/ mice did not differ
from that in HF-fed GR/ mice. The mechanism
underlying the blood pressure increase with the HF
diet remains unclear but may differ between genotypes.
In GRgeo/ mice, further RAAS activation may contrib-
ute. Plasma angiotensinogen levels were increased by
the HF diet in GRgeo/ mice, probably as a result of
increased hepatic expression of angiotensinogen, but
were unaffected in GR/ mice in which the diet-
induced increase in blood pressure was greater. The HF
diet had no effect on plasma aldosterone levels or
plasma renin activity in either genotype. Thus, activa-
tion of the systemic RAAS by the HF diet in GR/ mice
is ruled out. Elevated plasma glucocorticoid levels drive
hypertension in both humans and rodents (1, 54).
However, the underlying mechanisms remain contro-
versial but are likely to include changes in the sympa-
thetic nervous system. In this regard, it is of note that
adrenal catecholamines, implicated in the HF diet-
induced hypertension (53), are reduced in GR/ mice
(11, 34). It will be of interest, in future work, to
determine whether sympathetic nervous system activity
is altered in GRgeo/ mice.
In humans, polymorphisms in the GR gene associ-
ated with hypersensitivity or hyposensitivity to glucocor-
ticoids in a dexamethasone suppression test have been
variably associated with differences in body mass index,
waist-hip ratio, altered body composition, and meta-
bolic parameters (reviewed in ref. 14) as well as differ-
ences in blood pressure (55–59). However, the associ-
ation studies (14) are controversial and may depend on
age, gender, and ethnic background. The data re-
ported here provide insights into that heterogeneity. In
our model of glucocorticoid resistance due to 	50%
reduction in GR density, the observed physiological
differences between genotypes depend on environ-
ment. Thus, several of the differences between geno-
types are abolished or reduced after the HF diet. If the
same applies in humans, then (for example) obesity or
other chronic stress may mask differences in blood
pressure between populations with different GR poly-
morphisms.
Glucocorticoids form part of important homeostatic
control mechanisms that are critical in adapting to
environmental challenges. Thus, they maintain stability
through change over time (allostasis; reviewed in refs.
60, 61). GRgeo/ mice do not show the normal adap-
tions to the HF diet; they have an attenuated blood
pressure response and do not show the alterations in
adrenal size and HPA axis activity seen in WT mice.
Consequently, basal corticosterone levels are normal-
ized between genotypes after the HF diet. Moreover,
GRgeo/ mice accumulated more hepatic triglyceride,
possibly because of inadequate adaption to excessive
dietary fat/energy intake and the need to protect vital
organs. Continued excessive lipid accumulation in the
liver may, in turn, lead to insulin resistance and meta-
bolic disease. GR density is likely to be limiting in other
systems in adaption to environmental stressors. Mice
heterozygous for inactivating mutations in GR show
reduced coping behavior in a mouse correlate of
depression, with compromised indicators of neural
plasticity (40), whereas overexpression of GR results in
resistance to stress and robust protection against endo-
toxins. These adaptive or “remodeling” effects of glu-
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cocorticoids in the adult response to the HF diet are
reminiscent of the prenatal “programming” effects of
glucocorticoids (reviewed in ref. 62) where exposure of
the late fetus to glucocorticoids permanently programs
tissue systems throughout life, including blood pres-
sure, glucose/lipid homeostasis, and tissue GR density
itself. It will be of great interest to determine whether
GR density influences the prenatal programming ef-
fects of glucocorticoids in the same way that it alters the
postnatal blood pressure and HPA adaptions to a
chronic HF diet.
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